Chemoinformaics analysis of ent-labd-8(17),13-dien-15,16-olide-19-oic acid (pinusolidic acid)
| Molecular Weight | 332.44 | nRot | 4 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 18 |
| Exact Molecular Weight | 332.199 | nRing | 3 |
| Solubility: LogS | -4.295 | nHRing | 1 |
| Solubility: LogP | 3.635 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 55.2782 |
| nHD | 1 | BPOL | 31.5618 |
| QED | 0.778 |
| Synth | 4.253 |
| Natural Product Likeliness | 2.344 |
| NR-PPAR-gamma | 0.825 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -5.597 |
| MDCK | 0.0000125 |
| BBB | 0.089 |
| PPB | 0.958258 |
| VDSS | 0.928 |
| FU | 0.0247812 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.448 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.244 |
| CYP2c9-inh | 0.261 |
| CYP2c9-sub | 0.154 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.32 |
| CYP3a4-inh | 0.046 |
| CYP3a4-sub | 0.114 |
| CL | 1.208 |
| T12 | 0.388 |
| hERG | 0.003 |
| Ames | 0.013 |
| ROA | 0.552 |
| SkinSen | 0.047 |
| Carcinogencity | 0.367 |
| EI | 0.233 |
| Respiratory | 0.929 |
| NR-Aromatase | 0.085 |
| Antiviral | Yes |
| Prediction | 0.731267 |